Destination of choice for international investors

Catalonia has been named the top large region in fDi’s European Cities and Regions of the Future 2018/19 ranking for its FDI Strategy.

Financial Times

Since 2008, at the beginning of the recession, investments in Catalonia’s life sciences and healthcare companies has multiplied by 12. Specifically, in the 2015-2017 period, BioRegion start-ups have attracted almost €340 M in investment, more than threefold the amount reached in 2013-2015.

The financing raised in the BioRegion of Catalonia is on the upswing, especially regarding private investment (IN M€)
Destination 16.3 2011 27.3 27.3 27.3 21.9 2012 27.3 27.3 27.3 40.4 2013 27.3 27.3 27.3 36.2 2014 27.3 27.3 27.3 27.3 65.4 2015 27.3 27.3 164.3 2016 27.3 27.3 27.3 27.3 107.3 135.8 2017 27.3 27.3 27.3 IPO PUBLIC VC INVESTMENT CO-DEVELOPMENT OR COLLABORATION AGREEMENTS MOVING AVERAGE

In €M. Source: Biocat

Besides local specialized investors, Catalonia is seeing spectacular growth in international investors participating in life sciences and healthcare companies. In the past 10 years, international investors in the BioRegion have increased from 0 to more than 40, and have specifically multiplied by 5 in the last 4 years alone.

Number of international investors participating in companies in the BioRegion

Source: Biocat (June 2018)

International investors participating in companies in the BioRegion come from 16 different countries

Source: Biocat

Some BioRegion firms are success stories in terms of fundraising, both in the €11-50 M and the €1-10 M ranges. In 2015-2017 alone, +210 investment operations have taken place
€1-10 M
€11-50 M
2015
  • ClinicPoint
  • Galgo Medical
  • Genmedica Therapeutics
  • Greenaltech
  • iSalud
  • Medtep
  • Psious
  • Top Doctors
  • Transplant Biomedicals
Minoryx Therapeutics
Oryzon Genomics
2016
  • Albajuna Therapeutics
  • Bioprognos
  • Cebiotex
  • Cuantum Medical Cosmetics
  • IDP Pharma
  • Inbiomotion
  • Iproteos
  • Leukos Biotech
  • Pangaea Oncology
  • Peptomyc
  • Promofarma
  • Thrombotargets Europe
  • AB-Biotics
  • Aelix Therapeutics
  • Oryzon Genomics
  • STAT-Dx
2017
  • Bionure
  • Bwom Technologies
  • Glycardial Diagnostics
  • Devicare
  • iMicroQ
  • Inkemia IUCT Group
  • Linkcare
  • QMENTA
  • Peptomyc
  • SOM Biotech
  • Transmural Biotech
  • Top Doctors
  • Transplant Biomedicals
  • Anaconda Biomed
  • Oryzon Genomics
2018
  • Ahead Therapeutics
  • Bionure
  • Elma Care
  • Mediquo
  • ProteoDesign
  • Abac Therapeutics

Source Biocat (May 2018)